Skip to main content
OpenTrials

Clinical trial condition

Chronic Myeloid Leukemia

Explore clinical trials studying Chronic Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

187 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myeloid Leukemia trial results

Active, not recruiting

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT05362773

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Chronic Disease, +37 more
Locations
  • Colorado Blood Cancer Network Denver, Colorado, United States
  • University of Maryland, Greenbaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • START - Midwest Grand Rapids, Michigan, United States
View Trial Details
Active, not recruiting

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

NCT06092879

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Angers, France
  • Novartis Investigative Site Limoges, Haute Vienne, France
  • Novartis Investigative Site Saint Priest Jarez, Pays de la Loire Region, France
  • Novartis Investigative Site Aix-en-Provence, France
View all 52 locations
View Trial Details
Active, not recruiting

Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

NCT04626024

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
Locations
  • Baylor College of Medicine- McNair Campus Houston, Texas, United States
  • Ben Taub General Hospital Houston, Texas, United States
  • CHI St. Luke's Health Baylor College of Medicine Medical Center Houston, Texas, United States
  • Harris Health System- Smith Clinic Houston, Texas, United States
View Trial Details
Active, not recruiting

2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients

NCT02917720

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Universitätsmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany
  • Klinikum rechts der Isar München, Bavaria, Germany
  • Medizinische Hochschule Hannover Hannover, North Rhine-Westphalia, Germany
View all 15 locations
View Trial Details
Active, not recruiting

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

NCT04233346

Conditions
Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View all 14 locations
View Trial Details

Related conditions